Subsequent event (Details) |
Feb. 04, 2026
Y
shares
$ / shares
|
Oct. 15, 2025
USD ($)
$ / shares
|
Dec. 31, 2025
USD ($)
|
|---|---|---|---|
| Renal Anti-Fibrotic Therapeutic Program | |||
| Subsequent events | |||
| Consideration | $ 3,000,000 | ||
| Issue price | $ / shares | $ 0.86 | ||
| Cash finders' fee, percentage | 5.00% | ||
| Cash finders' fee, amount | $ 250,000 | ||
| Term of acquisition from execution of term sheet | 90 days | ||
| Termination fees | $ 50,000 | ||
| Deferred acquisition costs | $ 293,803 | ||
| Deferred cash finder fees | $ 200,000 | ||
| Offering | Director | |||
| Subsequent events | |||
| Options to purchase common shares issued | shares | 20,000 | ||
| Share price | $ / shares | $ 0.69 | ||
| Term of options granted | Y | 5 |
| X | ||||||||||
- Definition The option life of share options granted. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. No definition available.
|
| X | ||||||||||
- Definition The exercise price of share options granted. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of share options granted in a share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share price of saleable stock paid or offered to be paid by acquirer in asset acquisition. No definition available.
|
| X | ||||||||||
- Definition The period from the execution of the agreement, within which the acquisition is considered to be completed. No definition available.
|
| X | ||||||||||
- Definition The amount of termination fees, issued in common shares, under the asset acquisition. No definition available.
|
| X | ||||||||||
- Definition Amount of cash finder fees. No definition available.
|
| X | ||||||||||
- Definition Cash finder fees, expressed as a percentage of transaction value. No definition available.
|
| X | ||||||||||
- Definition Costs directly attributable to a asset acquisition which are deferred at the end of the reporting period. No definition available.
|
| X | ||||||||||
- Definition Costs directly attributable to finder fees which are deferred at the end of the reporting period. No definition available.
|
| X | ||||||||||
- Definition Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|